COVID-19 Guidance for Opioid Treatment Programs
Submitted by Edie
- 20 March 2020
The Substance Abuse and Mental Health Services Administration (SAMHSA) has developed new guidelines for professionals and organisations delivering substance use treatment in the US.
The guidelines cover.
- Guidance on pharmacotherapy for opioid use disorder (OUD) availability in circumstances in which patients may be exposed to highly contagious infectious agents (such as COVID-19)
- Opioid Treatment Programme Guidance for Patients Quarantined at Home with the Coronavirus
